DNA methylation profile of genes involved in inflammation and autoimmunity in inflammatory bowel disease

Medicine (United States)

Volumn 93, Issue 28, 2014, Pages e309-

  Karatzas, Pantelis S ^a   Mantzaris, Gerassimos J ^a   Safioleas, Michael ^b   Gazouli, Maria ^c  

^a EVANGELISMOS HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CINTREDEKIN BESUDOTOX; CXCL14 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 17; INTERLEUKIN 17C; INTERLEUKIN 4 RECEPTOR; TRANSCRIPTION FACTOR GATA 3; DNA;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; MALE; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE; ULCERATIVE COLITIS; BIOPSY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; GENETICS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; METABOLISM; PATHOLOGY;

ADULT; AUTOIMMUNITY; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DNA; DNA METHYLATION; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84920122540     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000309     Document Type: Article

References (27)

1. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008; 8: 458-466.
2. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010; 28: 573-621.
3. Van Limbergen J, Wilson DC, Satsangi J. The genetics of Crohn's disease. Annu Rev Genomics Hum Genet. 2009; 10: 89-116.
4. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007; 39: 596-604.
5. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207-211.
6. Toyota M, Itoh F, Kikuchi T, et al. DNA methylation changes in gastrointestinal disease. J Gastroenterol. 2002; 37(Suppl 14): 97-101.
7. Maeda O, Ando T, Watanabe O, et al. DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease: a mini review. Inflammopharmacology. 2006; 14: 204-206.
8. Cooke J, Zhang H, Greger L, et al. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm Bowel Dis. 2012; 18: 2128-2137.
9. Dachuan J. Circulating DNA-important biomarker of cancer. J Mol Biomarkers Diagn [Internet]. 2012[cited 2014 Jun 11]; Available from: http://www.omicsonline.org/2155-9929/2155-9929-S2-009.php.
10. Zekri AE-RN, Nassar AA-M, El-Din El-Rouby MN, et al. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation. Asian Pac J Cancer Prev APJCP. 2013; 14: 6721-6726.
11. Jiang W, Su J, Zhang X, et al. Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease. Inflamm Res Off J Eur Histamine Res Soc Al. 2014; 63: 943-950.
12. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
13. Franke A, Balschun T, Karlsen TH, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008; 40: 713-715.
14. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411: 599-603.
15. Stylianou E. Epigenetics: the fine-tuner in inflammatory bowel disease? Curr Opin Gastroenterol. 2013; 29: 370-377.
16. Mendoza JL, Abreu MT. Biological markers in inflammatory bowel disease: practical consideration for clinicians. Gastroentérologie Clin Biol. 2009; 33(Suppl 3): S158-S173.
17. Tahara T, Shibata T, Nakamura M, et al. Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int J Mol Med. 2009; 23: 521-527.
18. Wang F-Y, Arisawa T, Tahara T, et al. Aberrant DNA methylation in ulcerative colitis without neoplasia. Hepatogastroenterology. 2008; 55: 62-65.
19. Kuester D, Guenther T, Biesold S, et al. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitisassociated carcinoma. Pathol Res Pract. 2010; 206: 616-624.
20. Cooke J, Zhang H, Greger L, et al. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm Bowel Dis. 2012; 18: 2128-2137.
21. Hu C, Lin F, Zhu G, et al. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer. Int J Oncol. 2013; 43: 1487-1494.
22. Z'Graggen K, Walz A, Mazzucchelli L, et al. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology. 1997; 113: 808-816.
23. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314: 1461-1463.
24. Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008; 40: 1319-1323.
25. Mannon P, Reinisch W. Interleukin 13 and its role in gut defence and inflammation. Postgrad Med J. 2013; 89: 448-456.
26. Adalsteinsson BT, Gudnason H, Aspelund T, et al. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS ONE. 2012; 7: e46705.
27. Reinius LE, Acevedo N, Joerink M, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE. 2012; 7: e41361.